Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
Clinical trial NCT04820907 · COMPLETED
Trial details
- NCT number
- NCT04820907
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2021-09-30
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.